NewEdge Wealth LLC Acquires New Shares in The Cooper Companies, Inc. $COO

NewEdge Wealth LLC acquired a new position in The Cooper Companies, Inc. (NASDAQ:COO) in the second quarter, according to its most recent disclosure with the Securities & Exchange Commission. The institutional investor acquired 36,043 shares of the medical device company’s stock, valued at approximately $2,585,000.

A number of other institutional investors have also added to or reduced their stakes in COO. Generation Investment Management LLP bought a new stake in shares of Cooper Companies in the 2nd quarter valued at about $356,304,000. Danske Bank A S bought a new position in shares of Cooper Companies during the second quarter valued at approximately $7,077,000. Diversify Advisory Services LLC bought a new position in shares of Cooper Companies during the second quarter valued at approximately $1,704,000. Wealthfront Advisers LLC purchased a new position in Cooper Companies during the second quarter valued at approximately $605,000. Finally, Figure 8 Investment Strategies LLC purchased a new position in Cooper Companies during the second quarter valued at approximately $626,000. Hedge funds and other institutional investors own 24.39% of the company’s stock.

Wall Street Analyst Weigh In

A number of research firms have weighed in on COO. Weiss Ratings lowered Cooper Companies from a “hold (c-)” rating to a “sell (d)” rating in a report on Monday, June 8th. BNP Paribas Exane cut their price target on Cooper Companies from $95.00 to $92.00 and set an “outperform” rating on the stock in a report on Monday, June 8th. Mizuho set a $85.00 price target on Cooper Companies and gave the stock an “outperform” rating in a research report on Thursday, June 4th. Wells Fargo & Company restated a “sell” rating and set a $66.00 price objective (down from $82.00) on shares of Cooper Companies in a research note on Friday, June 5th. Finally, Stifel Nicolaus dropped their price objective on Cooper Companies from $95.00 to $85.00 and set a “buy” rating on the stock in a research report on Friday, June 5th. One analyst has rated the stock with a Strong Buy rating, seven have issued a Buy rating, six have given a Hold rating and three have assigned a Sell rating to the company’s stock. According to data from MarketBeat.com, the company currently has an average rating of “Hold” and a consensus target price of $81.64.

Cooper Companies Stock Down 0.7%

Cooper Companies stock opened at $76.16 on Friday. The company has a debt-to-equity ratio of 0.23, a current ratio of 1.27 and a quick ratio of 0.78. The stock has a market capitalization of $14.85 billion, a price-to-earnings ratio of 64.54, a PEG ratio of 2.01 and a beta of 0.83. The Cooper Companies, Inc. has a 1-year low of $58.89 and a 1-year high of $89.83. The business has a fifty day moving average price of $71.76 and a 200-day moving average price of $71.12.

Cooper Companies (NASDAQ:COO) last announced its earnings results on Thursday, June 4th. The medical device company reported $1.21 earnings per share (EPS) for the quarter, beating the consensus estimate of $1.10 by $0.11. The company had revenue of $1.08 billion for the quarter, compared to analyst estimates of $1.05 billion. Cooper Companies had a return on equity of 10.88% and a net margin of 5.57%.The firm’s quarterly revenue was up 7.9% compared to the same quarter last year. During the same period in the prior year, the company posted $0.96 EPS. Cooper Companies has set its FY 2026 guidance at 4.580-4.660 EPS. Equities research analysts forecast that The Cooper Companies, Inc. will post 4.63 EPS for the current fiscal year.

Trending Headlines about Cooper Companies

Here are the key news stories impacting Cooper Companies this week:

• Positive Sentiment: The company’s latest reported quarter showed solid operating performance: adjusted earnings of $1.21 per share exceeded consensus by $0.11, revenue reached $1.08 billion versus expectations of $1.05 billion, and sales increased 7.9% year over year. COO also maintained fiscal 2026 EPS guidance of $4.58–$4.66.
• Neutral Sentiment: Recent headlines mentioning “Cooper,” “COO,” or cooperation—including Bass Oil’s Cooper Basin update, Wendy’s discussion of a chief operating officer role, and Trainline’s regulatory cooperation—do not concern The Cooper Companies and are not relevant catalysts for COO.
• Negative Sentiment: With no fresh corporate catalyst in the provided articles, the modest weakness may reflect normal trading, profit-taking, or valuation concerns. The stock trades at a relatively high price-to-earnings multiple of about 64.5, leaving shares sensitive to changes in investor expectations even after the recent earnings beat.

Cooper Companies Profile

Cooper Companies, Inc (NASDAQ: COO) is a global medical device company headquartered in San Ramon, California. Founded in 1958, the company has grown through strategic acquisitions and organic development to become a major provider of vision care and women’s health products. Cooper Companies operates through two primary business segments—CooperVision and CooperSurgical—each serving specialized markets within the healthcare industry.

The CooperVision segment develops, manufactures and markets a broad range of soft contact lenses, as well as related accessories.